Ownership history in IFG Advisory, LLC · 4 quarters on record
This page tracks every 13F SEC filing in which IFG Advisory, LLC reported a position in ADAPTIMMUNE THERAPEUTICS (ADAP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 11,725 | — | 0% | 0.00% | $2K | — |
| 2025 Q2 | ADDED | 11,725 | +1,725 | +17.2% | 0.00% | $3K | — |
| 2025 Q1 | REDUCED | 10,000 | -17,500 | -63.6% | 0.00% | $2K | — |
| 2024 Q3 | INITIATED | 27,500 | — | — | 0.00% | $26K | — |
As of 2025 Q4 — sorted by position size